DARZALEX (Daratumumab)
DARZALEX is indicated for the treatment of adult patients with multiple myeloma: in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for…
Janssen Biotech, Inc. Products: Prescription Medications Section
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj (human Recombinant))
DARZALEX FASPRO is a combination of daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase, indicated for the treatment of adult patients with: multiple…
INFLIXIMAB
Infliximab is a tumor necrosis factor (TNF) blocker indicated for: Crohn’s Disease: reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with…
REMICADE (INFLIXIMAB)
REMICADE is a tumor necrosis factor (TNF) blocker indicated for: Crohn’s Disease: reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with…
Rybrevant (Amivantamab)
RYBREVANT is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20…